BOLALARDA RESPIRATOR-SINSITIAL VIRUS INFEKSIYASI, EPIDEMIOLOGIYASI VA ZAMONAVIY PROFILAKTIKA CHORA-TADBIRLARI: MATERNAL VAKSINA VA MONOKLONAL ANTITANALARNING AHAMIYATI
Keywords:
respirator sinsitial virus infeksiyasi, chaqaloqlar oʻlimi, a va b genotiplar, nafas olish sistemasi a’zolari kasalliklari, gospitalizatsiya, monoklonal antitanalar, maternal vaksina, Nirsevimab va palivizumab monoklonal antitanalari, placebo guruhi, bronxopulmonal displaziya.Abstract
Mazkur maqolada aksariyat bolalarda va katta yoshdagi yurak kasalliklari va nafas olish tizimi kasalliklariga ega boʻlgan insonlarda ogʻir respirator tizim muammolarini keltirib chiqaradigan respirator sinsitial virus infeksiyasi, uning etiologiyasi, zamonaviy profilaktik chora-tadbirlari va bu boradagi ilmiy tadqiqotlar, zaruriy manbalar tahlil qilinadi [5, 6]. Hozirda koʻrilayotgan chora-tadbirlar samaradorligi va tadqiqotlar natijalari taqqoslanib, oʻrganiladi.
References
1. Dieussaert I., Karsten K., et al. RSV Prefusion F protein-Based Maternal Vaccine-Preterm Birth and Other Outcomes. New England Journal of Medicine. 2024;390:1009-1021.
2. Drysdale S.B., et al. Nirsevimab for Prevention of Hospitalizations Due to Respiratory Syncytial Virus in Infants. New England Journal of Medicine. 2023;389:2425-2435.
3. Griffin M.P., et al. Nirsevimab for Prevention of Respiratory Syncytial Virus in Healthy Late-Preterm and Term Infants. New England Journal of Medicine.
4. Kampmann B., Madhi S.A., Munjal I., et al. Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants. New England Journal of Medicine. 2023;388:1451-1464.
5. World Health Organization (WHO). Paediatric drug optimization for respiratory Syncytial virus (RSV). 2025.
6. World Health Organization (WHO). Respiratory Syncytial virus (RSV) Fact Sheet. 19 December 2025.
7. World Health Organization (WHO). Respiratory Syncytial virus (RSV) immunization products. 2025.
8. World Health Organization (WHO). WHO position paper on immunization to protect Infants against respiratory Syncytial virus disease. May 2025.
9. World Health Organization (WHO). RSV immunization resources and global disease burden in children.
